Brookings conference on post-market safety

Brookings Institution's Engelberg Center for Health Care Reform will hold a conference in Washington, D.C., June 13 on drug safety and post-market evidence, hosted by center Director Mark McClellan. During the conference, FDA Commissioner Andrew von Eschenbach and CDER Director Janet Woodcock are scheduled to discuss the agency's new Sentinel initiative, along with Richard Platt, Harvard University, Marcus Wilson, from WellPoint's HealthCore unit, and Janet Marchibroda, eHealth Initiative. Some details on the Sentinel project were announced by FDA May 22. Other conference participants will include Garry Neil, J&J, and Arnold Chan, i3 Drug Safety